Abstract:Mingsheng Lyu, 1, 2 Jingbo Qin, 3 Shuaiyang Huang, 2 Dongmei Shao, 4 Guirui Huang, 2 Fan Yang, 5, 6 Xuefeng Gong, 7 Shiyu Zhang, 2 Zhijie Zhang, 2 Ji Wang, 6 Hongsheng Cui 2 1 Center of Respiratory Disease, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China; 2 Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China; 3 Department of Geratology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China; 4 Department of Infectious Disease, Shunyi Hospital, Beijing Hospital of Traditional Chinese Medicine, Beijing, People's Republic of China; 5 College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China; 6 National Institute of Traditional Chinese Medicine (TCM) Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China; 7 Department of Traditional Chinese Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China Correspondence: Hongsheng Cui, Department of Respiratory, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China, Email ; Ji Wang, National Institute of Traditional Chinese Medicine Constitution and Preventive Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China, Email Background: Tuo-Min-Ding-Chuan Decoction (TMDCD) is an effective traditional Chinese medicine (TCM) formula granule for allergic asthma (AA). Previous studies proved its effects on controlling airway inflammations, while the specific mechanism was not clear. Methods: We conducted a network pharmacology study to explore the molecular mechanism of TMDCD against AA with the public databases of TCMSP. Then, HUB genes were screened with the STRING database. DAVID database performed GO annotation and KEGG functional enrichment analysis of HUB genes, and it was verified with molecular docking by Autodock. Then, we built a classic ovalbumin-induced allergic asthma mice model to explore the mechanism of anti-inflammation effects of TMDCD. Results: In the network pharmacology study, we found out that the potential mechanism of TMDCD against AA might be related to NOD-like receptor (NLR) signaling pathway and Toll-like receptor (TLR) signaling pathway. In the experiment, TMDCD showed remarkable effects on alleviating airway inflammations, airway hyperresponsiveness (AHR), and airway remodeling in the asthmatic mice model. Further molecular biology and immunohistochemistry experiments suggested TMDCD could repress TLR4-NLRP3 pathway-mediated pyroptosis-related gene transcriptions to inhibit expressions of target proteins. Conclusion: TMDCD could alleviate asthmatic mice model airway inflammations by regulating TLR4-NLRP3 pathway-mediated pyroptosis. Keywords: Tuo-Min-Ding-Chuan Decoction, allergic asthma, TLR4, NLRP3, pyroptosis, network pharmacology, traditional Chinese medicine Bronchial asthma is a common respiratory disease characterized by chronic airway inflammations. Epidemiological data show that asthma has a high incidence all over the world, with nearly 300 million patients worldwide and 45.7 million adult patients in China. 1,2 Recurrent asthma attacks not only seriously reduce the quality of life of asthmatic patients but also bring serious medical burdens to the world. Usually, the phenotypes of bronchial asthma are classified into early-onset AA, late-onset persistent eosinophilic asthma, exercise-induced asthma, obesity-related asthma, neutrophilic asthma, smoking asthma, etc. 3 AA accounts for more than 50% of the adult asthma patients and 80% of the childhood patients. 4 The pathogenesis of AA is complex; previous studies hold the view that the adaptive immune system mainly participates in the dysregulation of allergy and induces airway inflammations, which is the basis of AHR and airway remodeling. The activation of type 2 helper T cell (Th), the crucial player in humans' adaptive immune responses, brings releases of type 2 inflammatory cytokines such as interleukin (IL)-4, IL-5, and IL-13. Nevertheless, recognition of environment antigens by innate immune cells should not be ignored for the activation of adaptive immune responses, which play a key role in priming naive T cells and generating adaptive immunities. 5 Following recent studies, we know that the primary means of inducing innate immune responses were -Abstract Truncated-

Prevention of allergic airway hyperresponsiveness and remodeling in mice by Astragaliradix Antiasthmatic decoction

Carbocistein improves airway remodeling in asthmatic mice

Altered Frequency of NK Cells and Treg Cells by Astragalus Polysaccharide Combined with Budesonide in Asthma Model Mice

Assessment of Tumor Growth Factor-Β1 Neutralizing Antibody in the Treatment of Allergic Rhinitis and Asthma.

Effect of Astragali-Cordyceps Mixtura on TGF-β/Smad Signal Pathway in the Lung of Asthma Airway Remodeling

Astragalus Membranaceus Prevents Airway Hyperreactivity in Mice Related to Th2 Response Inhibition.

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

Protective effects of astragaloside IV against ovalbumin-induced allergic rhinitis are mediated by T-box protein expressed in T cells/GATA-3 and forkhead box protein 3/retinoic acid-related orphan nuclear receptor γt

Astragalus Polysaccharide Alleviates Asthma by Modulating Gut Microbiota and Serum Metabolomics

Protective Effects and Active Ingredients of Salvia Miltiorrhiza Bunge Extracts on Airway Responsiveness, Inflammation and Remodeling in Mice with Ovalbumin-Induced Allergic Asthma

Tuo-Min-Ding-Chuan Decoction Alleviate Ovalbumin-Induced Allergic Asthma by Inhibiting Mast Cell Degranulation and Down-Regulating the Differential Expression Proteins

Anti-Cd69 Monoclonal Antibody Treatment Inhibits Airway Inflammation in A Mouse Model of Asthma

Schisandrol A Alleviates Allergic Asthma in Mice via Regulating the NF-κB/IκBα and Nrf2/HO-1 Signaling Pathways

CD4+CD25+Foxp3+ T cells contribute to the antiasthmatic effects of Astragalus membranaceus extract in a rat model of asthma.

Investigation of the Anti-Asthmatic Activity of Oridonin on A Mouse Model of Asthma

An Amide Alkaloid Isolated from Ephedra sinica Ameliorates OVA-Induced Allergic Asthma by Inhibiting Mast Cell Activation and Dendritic Cell Maturation

The Anti-Inflammatory Mechanism of Astragaloside in the Recurrences of Asthma Mice

Tuo-Min-Ding-Chuan Decoction Alleviates Airway Inflammations in the Allergic Asthmatic Mice Model by Regulating TLR4-NLRP3 Pathway-Mediated Pyroptosis: A Network Pharmacology and Experimental Verification Study

Pudilan Anti-inflammatory Oral Liquid and Organic Acid Component from Taraxaci Herba Attenuate Allergic Asthma in Young Mice through Toll-like Receptor 2/Toll-like Receptor 4 Signaling Pathway

Emodin ameliorates ovalbumin-induced airway remodeling in mice by suppressing airway smooth muscle cells proliferation

Louki Zupa decoction attenuates the airway inflammation in acute asthma mice induced by ovalbumin through IL-33/ST2-NF-κB/GSK3β/mTOR signalling pathway.